Biological E. Limited has entered into an agreement with Janssen Pharmaceutica NV, a subsidiary of Johnson & Johnson, for the manufacturing of drug substance and finished product of the company’s covid-19 vaccine candidate.
Biological E signs pact to manufacture J&J arm’s covid-19 vaccine
Date posted: Monday 17 August 2020